StockData
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR) stock

GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$18.17−0.40 (-2.15%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

Structure Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Structure Therapeutics's total assets was $1.43B at Jun 30, 2026. For fiscal 2025 it was $1.58B, up 75.3% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.58B+75.3%
FY2024Dec 31, 2024$903.33M+87.4%
FY2023Dec 31, 2023$482.02M+392.6%
FY2022Dec 31, 2022$97.85M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.43B+74.6%
Q1 FY2026Mar 31, 2026$1.51B+74.0%
Q4 FY2025Dec 31, 2025$1.58B+75.3%
Q3 FY2025Sep 30, 2025$832.16M-10.8%
Q2 FY2025Jun 30, 2025$816.44M-13.8%
Q1 FY2025Mar 31, 2025$866.55M+89.5%
Q4 FY2024Dec 31, 2024$903.33M+87.4%
Q3 FY2024Sep 30, 2024$933.22M+331.3%
Q2 FY2024Jun 30, 2024$947.03M+312.8%
Q1 FY2024Mar 31, 2024$457.23M+84.8%
Q4 FY2023Dec 31, 2023$482.02M+392.6%
Q3 FY2023Sep 30, 2023$216.37M–
Q2 FY2023Jun 30, 2023$229.43M–
Q1 FY2023Mar 31, 2023$247.35M–
Q4 FY2022Dec 31, 2022$97.85M–

More Structure Therapeutics figures

See a number that looks wrong?